tetano
Editor, Senior Moderator
Chem Biol Drug Des. 2015 Jan 20. doi: 10.1111/cbdd.12520. [Epub ahead of print]
[h=1]Synthesis and preliminary antiviral activities of piperidine-substituted purines against HIV and influenza A/H1N1 infections.[/h] Kang D[SUP]1[/SUP], Fang Z, Huang B, Zhang L, Liu H, Pannecouque C, Naesens L, De Clercq E, Zhan P, Liu X.
[h=3]Author information[/h]
[h=3]Abstract[/h] We have developed a series of N[SUP]2[/SUP] -(1-(substituted-aryl)piperidin-4-yl)-N[SUP]6[/SUP] -mesityl-9H-purine-2,6-diamine derivatives as potent antiviral agents. Preliminary biological evaluation indicated that nearly half of them possessed remarkable HIV inhibitory potencies in cellular assays. In particular, FZJ13 appeared to be the most notable one, which displayed anti-HIV-1 activity compared to 3TC. Moreover, an unexpected finding was that FZJ05 displayed significant potency against influenza A/H1N1 (strain A/PR/8/34) in MDCK cells with EC[SUB]50[/SUB] values much lower than those of ribavirin, amantadine and rimantadine. The results suggest that these novel purine derivatives have the potential to be further developed as new therapeutic agents against HIV-1 or influenza virus. This article is protected by copyright. All rights reserved.
This article is protected by copyright. All rights reserved.
[h=4]KEYWORDS:[/h] HIV ; SAR ; Bioactivity; Heterocycle; Influenza virus; NNRTIs; Synthesis
PMID: 25600073 [PubMed - as supplied by publisher]
[h=1]Synthesis and preliminary antiviral activities of piperidine-substituted purines against HIV and influenza A/H1N1 infections.[/h] Kang D[SUP]1[/SUP], Fang Z, Huang B, Zhang L, Liu H, Pannecouque C, Naesens L, De Clercq E, Zhan P, Liu X.
[h=3]Author information[/h]
[h=3]Abstract[/h] We have developed a series of N[SUP]2[/SUP] -(1-(substituted-aryl)piperidin-4-yl)-N[SUP]6[/SUP] -mesityl-9H-purine-2,6-diamine derivatives as potent antiviral agents. Preliminary biological evaluation indicated that nearly half of them possessed remarkable HIV inhibitory potencies in cellular assays. In particular, FZJ13 appeared to be the most notable one, which displayed anti-HIV-1 activity compared to 3TC. Moreover, an unexpected finding was that FZJ05 displayed significant potency against influenza A/H1N1 (strain A/PR/8/34) in MDCK cells with EC[SUB]50[/SUB] values much lower than those of ribavirin, amantadine and rimantadine. The results suggest that these novel purine derivatives have the potential to be further developed as new therapeutic agents against HIV-1 or influenza virus. This article is protected by copyright. All rights reserved.
This article is protected by copyright. All rights reserved.
[h=4]KEYWORDS:[/h] HIV ; SAR ; Bioactivity; Heterocycle; Influenza virus; NNRTIs; Synthesis
PMID: 25600073 [PubMed - as supplied by publisher]